A change in drug clearance with age is considered an important factor in determining the high prevalence of adverse drug reactions associated with prescribing medications for the elderly. Despite this, no general principles have been available to guide drug administration in the elderly, although a substantial body of clearance and metabolism data has been generated in humans and experimental animals. A review of age-related change in drug clearances established that patterns of change are not simply explained in terms of hepatic blood flow, hepatic mass and protein binding changes. In particular, the maintained clearance of drugs subject to conjugation processes while oxygen-dependent metabolism declines, and all in vitro tests of enzyme function have been normal, requires new explanations.
Reduction in hepatic oxygen diffusion as part of a general change in hepatocyte surface membrane permeability and conformation does provide one explanation for the paradoxical patterns of drug metabolism, and increased hepatocyte volume would also modify oxygen diffusion path lengths (the ‘oxygen diffusion barrier’ hypothesis). The reduction in clearances of high extraction drugs does correlate with observed reduction in hepatic perfusion.
Dosage guidelines emerge from these considerations. The dosage of high clearance drugs should be reduced by approximately 40% in the elderly while the dosage of low clearance drugs should be reduced by approximately 30%, unless the compound is principally subject to conjugation mechanisms. If the hepatocyte diffusion barrier hypothesis is substantiated, this concept may lead to therapeutic (preventative and/or restorative) approaches to increased hepatocyte oxygenation in the elderly. This may lead to approaches for modification of the aging process in the liver.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Offerhaus L. Drags for the elderly. 2nd ed. Copenhagen: WHO Regional Publications, 1997.
Le Couteur DG, Johnson AG. Drags and the elderly: prescription idiosyncrasies. Mod Med. 1997; 40: 30–7.
Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ. 1969; I: 536–9.
Lumley CE, Walker SR, Hall GC, et al. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986; 1: 205–12.
Hutchinson TA, Flegel KM, Kramer MS, et al. Frequency, severity and risk factors for adverse drag reactions in adult outpatients. J Chron Dis. 1986; 39: 533–42.
Monette J, Gurwitz JH, Avom J. Epidemiology of adverse drag events in the nursing home setting. Drugs Aging. 1995; 7: 203–11.
Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drag reactions. Ann Intern Med. 1991; 114: 956–67.
Popper H. Aging and the liver. Prog Liver Dis. 1986; VIII: 659–83.
Vestal RE. Aging and determinants of hepatic drug clearance. Hepatology. 1989; 9: 331–4.
Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet. 1997; 33: 302–12.
Schmucker DL. Aging and drug disposition: an update. Pharmacol Rev. 1979; 30: 133–48.
James OFW. Drugs and the ageing liver. J Hepatol. 1985; 1: 431–5.
Woodhouse K. Drags and the liver. III: aging of the liver and the metabolism of drags. Biopharm Drug Dispos. 1992; 13: 311–20.
Woodhouse KW, Mutch E, Williams FM. The effect of age on pathways of drug metabolism in human liver. Age Ageing. 1984; 13: 328–34.
Wynne HA, James OFW. The aging liver. Age Ageing. 1990; 19: 1–3.
Wilkinson GR. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev. 1997; 27: 129–59.
Boyd E. Normal variability in weight of the adult human liver and spleen. Arch Pathol. 1933; 16: 350–72.
Calloway NO, Foley CF, Lagerbloom P. Uncertainties in geriatric data. II: organ size. J Am Geriatr Soc. 1965; 13: 20–8.
Tauchi H, Sato T. Hepatic cells of the aged. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 3–20.
Bach B, Hansen JM, Kampmann JP, et al. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin Pharmacokinet. 1981; 6: 389–96.
Schnegg M, Lauterburg BH. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. J Hepatol. 1986; 3: 164–71.
Wynne HA, Cope LH, James OFW, et al. The effect of age and frailty upon acetanilide clearance in man. Age Ageing. 1989; 18: 415–8.
Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989; 9: 297–301.
Varga F, Fischer E. Age dependent changes in blood supply of the liver and in the biliary excretion of eosine in rats. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 327–42.
Wiener E, Rabinovici N. Liver haemodynamics and age. Proc Soc Exp Biol Med. 1961; 108: 752–4.
Montgomery PR, Sitar DS. Hepatic uptake of indocyanine green and perfusion rate in rats: effect of age and albumin concentration. Can J Physiol Pharmacol. 1988; 66: 592–5.
Le Couteur DG, Rivory LP, Yi C, et al. Aging, acute oxidative injury and hepatocellular glucose transport in the rat. Int Hepatol Commun. 1995; 3: 244–53.
Martin G, Sewell B, Yeomans ND, et al. Ageing has no effect on the volume density of hepatocytes, reticulo-endothelial cells or the extracellular space in livers of female Sprague-Dawley rats. Clin Exp Pharmacol Physiol. 1992; 19: 537–9.
Schmucker DL. A quantitative morphological evaluation of hepatocytes in young mature and senescent fischer 344 male rats. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 21–38.
Pieri C, Zs-Nagy I, Mazzufferri G, et al. The aging of rat liver as revealed by electron microscopic morphometry. I: basic parameters. Exp Gerontol. 1975; 10: 291–304.
Van Bezooijen CFA. Influence of age-related changes in rodent liver morphology and physiology on drug metabolism: a review. Mech Ageing Devel. 1984; 25: 1–22.
Sastre J, Pallardo FV, Pla R, et al. Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology. 1996; 24: 1199–205.
Sherlock S, Beam AG, Billing BH, et al. Splanchnic blood flow in man by the bromosulfthalein method: the relation of peripheral plasma bromosulfthalein level to calculated flow. J Lab Clin Med. 1950; 35: 923–32.
Zoli M, Iervese T, Abbati S, et al. Portal blood flow and velocity in aging man. Gerontology. 1989; 35: 61–5.
Wynne HA, Goudevenos J, Rawlins MD, et al. Hepatic drug clearance: the effect of age using indocyanine green as a model compound. Br J Clin Pharmacol. 1990; 30: 634–7.
Le Couteur DG, Rivory LP, Roberts MS, et al. Aging and the response of the isolated perfused rat liver to vasoactive drugs. Biochem Pharmacol. 1992; 43: 913–5.
Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology. 1987; 7: 952–63.
Handler JA, Genell CA, Goldstein RS. Hepatobiliary function in senescent male Sprague-Dawley rats. Hepatology. 1994; 19: 1496–503.
Finch CE. Enzyme activities, gene function and aging in mammals. Exp Gerontol. 1972; 7: 53–67.
Ward W, Richardson A. Effect of age on liver protein synthesis and degradation. Hepatology. 1991; 5: 935–49.
Greenblatt DJ. Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc. 1979; 27: 20–2.
Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the Normative Aging Study. J Gerontol. 1988; 43: M18–20.
Chen JC, Ove P, Lansing AI. In vitro synthesis of microsomal protein and albumin in young and old rats. Biochim Biophys Acta. 1977; 312: 598–607.
Santa Maria C, Ayala A, Revilla E. Changes in Superoxide dismutase activity in liver and lung of old rats. Free Radical Res. 1996; 25: 401–5.
Stio M, Iantomasi T, Favilli F, et al. Glutathione metabolism in heart and liver of the aging rat. Biochem Cell Biol. 1994; 72: 58–61.
Rikans LE. Influence of aging on the susceptibility of rats to hepatoxic injury. Toxicol Appl Pharmacol. 1984; 73: 243–9.
Rikans LE. Age-related differences in the susceptibility to druginduced hepatotoxicity. In: Kitani K, editor. Liver and aging. Amsterdam: Excerpta Medica, 1991: 59–71.
Le Couteur DG, Rivory LP, Pond SM. The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. Transplantation. 1994; 58: 531–6.
Mooney H, Roberts R, Cooksley WGE, et al. Alterations in liver with aging. Clin Gastroenterol. 1985; 14: 757–71.
Kampmann JP, Sinding J, Moller-Jorgensen I. Effect of age on liver function. Geriatrics. 1975; 30: 91–5.
Gibson PR, Dudley FL. Ischemic hepatitis: clinical features, diagnosis, and prognosis. Aust NZ J Med. 1984; 14: 822–5.
Kato R, Vassanelli P, Frontino G. Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age. Biochem Pharmacol. 1964; 12: 1037–51.
Iwamoto K, Watanabe J, Araki K, et al. Effect of age on the hepatic clearance of propranolol in rats. J Pharm Pharmacol. 1985; 37: 466–70.
Schmucker DL, Woodhouse KW, Wang RK, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther. 1990; 48: 365–74.
Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994; 270: 414–23.
Brodie MJ, Boobis AR, Bulpitt CJ, et al. Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol. 1981; 20: 39–46.
Hunt CM, Strater S, Stave GM. Effect of normal aging on the activity of human hepatic cytochrome P450IIE1. Biochem Pharmacol. 1990; 40: 1666–9.
Herd B, Wynne HA, Wright P, et al. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions. Br J Clin Pharmacol. 1991; 32: 768–70.
Durnas C, Loi CM, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet. 1990; 19: 359–89.
Vestal RE, Wood AJJ, Branch RA, et al. Studies of drug disposition in the elderly using model compounds. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 343–57.
Rowland M, Tozer TN. Clinical Pharmacokinetics: concepts and applications. Philadelphia: Lea & Febiger, 1989.
Angus PW, Mihaly GW, Morgan DJ, et al. Oxygen dependence of omeprazole clearance and suphone and suphide metabolite formation in the isolated perfused rat liver. J Pharmacol Ther. 1989; 250: 1043–7.
Angus PW, Mihaly GW, Morgan DJ, et al. Oxygen dependence of salbutamol elimination by the isolated perfused rat liver. Biochem Pharmacol. 1989; 38: 1443–9.
Angus PW, Morgan DJ, Smallwood RA. Hypoxia and hepatic drug metabolism: clinical implications. Aliment Pharmacol Ther. 1990; 4: 213–25.
McLean AJ, Morgan DJ. Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet. 1991; 21: 42–69.
Morgan DJ, McLean AJ. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease: an update. Clin Pharmacokinet. 1995; 29: 1–22.
Owens N, Fretwell M, Willey C, et al. Distinguishing between the fit and frail elderly, and optimising pharmacotherapy. Drugs Aging. 1994; 4: 47–55.
Iber FL, Murphy PA, Connor ES. Age-related changes in the gastrointestinal system: effects on drug therapy. Drugs Aging. 1994; 5: 34–48.
Kitani K. Hepatic drug metabolism in the elderly. Hepatology. 1986; 6: 316–9.
Sotaneimi EA, Arranto AT, Pelkonen O, et al. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathological conditions. Clin Pharmacol Ther. 1997; 61: 331–9.
Verbeeck RK, Cardinal JA, Wallace SM. Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol. 1984; 27: 91–7.
Patterson M, Heazelwood R, Shithurst B, et al. Plasma protein binding of phenytoin in the aged: in vivo studies. Br J Clin Pharmacol. 1982; 13: 423–5.
Davis D, Grossman SH, Kitchell BB, et al. The effects of aging and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol. 1985; 19: 261–5.
Boudinot SG, Funderburg ED, Boudinot FD. Effects of age on the pharmacokinetics of piroxicam in rats. J Pharm Sci. 1993; 82: 254–7.
Andros E, Detmar-Hanna D, Suteparuk S, et al. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol. 1996; 50: 41–6.
Shepherd AM, Hewick DS, Moreland TA, et al. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977; 4: 315–20.
Schwartz JB, Capili H, Daugherty J. Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 1994; 55: 509–17.
Bernus I, Dickinson RG, Hooper WD, et al. Anticonvulsant therapy in aged patients: clinical pharmacokinetic considerations. Drugs Aging. 1997; 10: 278–89.
Wallace SM, Verbeeck RK. Plasma protein binding of drugs in the elderly. Clin Pharmacokinet. 1987; 12: 41–72.
Branch RA. Drugs as indicators of hepatic function. Hepatology. 1982; 2: 97–105.
Branch RA, Shand DG. Propranolol disposition in chronic liver disease: a physiological approach. Clin Pharmacokinet. 1976; 1: 264–79.
Greenblatt DJ, Divoll M, Abernethy DR, et al. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Br J Clin Pharmacol. 1982; 15: 303–9.
Varin F, Huet P-M. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest. 1985; 76: 1904–12.
Hickey PL, McLean AJ, Angus PW, et al. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver. Gastroenterology. 1996; 111: 1039–48.
Kassissia I, Rose CP, Goresky CA, et al. Flow-limited tracer oxygen distribution in the isolated perfused rat liver: effects of temperature and hematocrit. Hepatology. 1992; 16: 763–75.
Hickey PL, Angus PW, McLean AT, et al. Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. Gastroenterology. 1995; 108: 1504–9.
Rose CP, Goresky CA. Limitation of tracer oxygen uptake in the canine coronary circulation. Circ Res. 1985; 56: 57–71.
Blanchard J, Sawers SJA. Comparative pharmacokinetics of caffeine in young and elderly men. J Pharm Biopharm. 1983; 11: 109–29.
Pirke KM, Sintermann R, Vogt HJ. Testosterone and testosterone precursors in the spermatic vein and in the testicular tissue of old men: reduced oxygen suppy may explain the relative increase of testicular progesterone and 17a-hydroxyprogesterone content and production in old age. Gerontology. 1980; 26: 221–30.
Le Couteur D. The physiology of the aging liver. Brisbane: The University of Queensland, 1994.
Vaz M, Rajkumar C, Wong J, et al. Oxygen consumption in the heart, hepatomesenteric bed and brain in young and elderly human subjects and accompanying sympathetic nervous activity. Metabolism. 1996; 45: 1487–92.
De Leeuw AM, Brouwer A, Knook DL. Sinusoidal endothelial cells of the liver: fine structure and function in relation to age. J Electron Microsc Tech. 1990; 14: 218–36.
Guenard H, Marthan R. Pulmonary gas exchange in elderly subjects. Eur Resp J. 1996; 9: 2573–7.
Le Couteur DG, Rivory LP, Pond SM. Hepatic intracellular pH during the prereplicative period following partial hepatectomy. Am J Physiol. 1993; 264: G767–73.
McLean AJ, Le Couteur DG. The effect of age on the hepatocyte uptake of solutes [abstract]. Clin Pharmacol Ther 1998. In press.
Zs-Nagy I. The role of membrane structure and function in cellular aging: a review. Mech Ageing Devel. 1979; 9: 237–46.
Nokubo M. Physical-chemical and biochemical differences in liver plasma membranes in aging F-344 rats. J Gerontol. 1985; 40: 409–14.
Zs-Nagy I, Geynes M, Lustik G, et al. Age-dependent decrease of cell membrane permeability of rat hepatocytes as revealed by in vivo Rb+-uptake and release. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier Biomedical Press, 1982: 215–28.
Kitani K, Zsolnai-Nagy I, Kanai S, et al. Correlation between the biliary excretion of ouabain and the lateral mobility of hepatocyte plasma membrane proteins in the rat: the effects of age and spironolactone pretreatment. Hepatology. 1988; 8: 125–31.
Gentile S, Persico M, Orlando C, et al. Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). Scand J Clin Lab Invest. 1990; 50: 565–71.
Hegner D. Age-dependence of molecular and functional changes in biological membrane properties. Mech Ageing Devel. 1980; 14: 101–18.
About this article
Cite this article
Le Couteur, D.G., McLean, A.J. The Aging Liver. Clin Pharmacokinet 34, 359–373 (1998). https://doi.org/10.2165/00003088-199834050-00003
- Adis International Limited
- Hepatic Blood Flow
- Drug Clearance
- Intrinsic Clearance